Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):5010–5016. doi: 10.1128/iai.65.12.5010-5016.1997

The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate.

M Akkoyunlu 1, A Melhus 1, C Capiau 1, O van Opstal 1, A Forsgren 1
PMCID: PMC175723  PMID: 9393790

Abstract

The nonacylated form of protein D (PDm) of Haemophilus influenzae has been shown to induce the production of antibodies that are bactericidal to homologous and heterologous nontypeable H. influenzae (NTHi) strains. In this study, immunization of rats with lipoprotein D (LPD) induced higher levels of anti-protein D immunoglobulin G and A serum antibodies than immunization with PDm, and the bactericidal activities of sera from LPD-immunized rats were greater than those of sera from PDm-immunized rats. Immunization with LPD or PDm did not prevent the development of acute otitis media (AOM) when rats were challenged with 10(4) CFU of an NTHi strain. However, on the eighth day of bacterial challenge, 50% (5 of 10) of LPD-immunized rats had recovered from otitis media and 30% (3 of 10) had negative middle ear cultures, whereas only 30% (3 of 10) of PDm-immunized rats had recovered, though none was culture positive. Immunization with an inactivated homologous bacterial strain elicited 70% protection (i.e., 7 of 10 rats) in the rat otitis media model. LPD and PDm were also conjugated to the H. influenzae type b (Hib) capsular polysaccharide, polyribosyl ribitol phosphate (PRP), to test protein D-conjugated PRP vaccine's potential for protection against Hib infection. When two LPD-conjugated and two PDm-conjugated PRP vaccines, each containing a different protein concentration, and a tetanus toxoid-conjugated vaccine (ACT-HIB) were tested in the experimental model of rat otitis induced with a Hib strain (Minn A), both of the LPD-conjugated and one of the PDm-conjugated vaccines induced significant protection from AOM, the level of protection being highest in animals given the vaccine with the highest LPD content. Sera from these rats also manifested the highest anti-PRP and anti-LPD antibody levels and the highest bactericidal activities against a Hib strain and an NTHi strain.

Full Text

The Full Text of this article is available as a PDF (408.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akkoyunlu M., Forsgren A. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats. APMIS. 1996 Oct;104(10):709–717. [PubMed] [Google Scholar]
  2. Akkoyunlu M., Janson H., Ruan M., Forsgren A. Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect Immun. 1996 Nov;64(11):4586–4592. doi: 10.1128/iai.64.11.4586-4592.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akkoyunlu M., Ruan M., Forsgren A. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun. 1991 Apr;59(4):1231–1238. doi: 10.1128/iai.59.4.1231-1238.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barenkamp S. J., Bodor F. F. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media. Pediatr Infect Dis J. 1990 May;9(5):333–339. doi: 10.1097/00006454-199005000-00006. [DOI] [PubMed] [Google Scholar]
  5. Barenkamp S. J. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect Immun. 1996 Apr;64(4):1246–1251. doi: 10.1128/iai.64.4.1246-1251.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barenkamp S. J. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect Immun. 1986 May;52(2):572–578. doi: 10.1128/iai.52.2.572-578.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dabernat H., Delmas C., Rich C., Livrelli V., Joly B. Characterization of Haemophilus influenzae isolated from patients with otitis media. Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):219–225. doi: 10.1007/BF01963092. [DOI] [PubMed] [Google Scholar]
  8. DeMaria T. F., Murwin D. M., Leake E. R. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect Immun. 1996 Dec;64(12):5187–5192. doi: 10.1128/iai.64.12.5187-5192.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Decker M. D., Edwards K. M., Bradley R., Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992 Feb;120(2 Pt 1):184–189. doi: 10.1016/s0022-3476(05)80424-x. [DOI] [PubMed] [Google Scholar]
  10. Erdile L. F., Brandt M. A., Warakomski D. J., Westrack G. J., Sadziene A., Barbour A. G., Mays J. P. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun. 1993 Jan;61(1):81–90. doi: 10.1128/iai.61.1.81-90.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evans F. O., Jr, Sydnor J. B., Moore W. E., Moore G. R., Manwaring J. L., Brill A. H., Jackson R. T., Hanna S., Skaar J. S., Holdeman L. V. Sinusitis of the maxillary antrum. N Engl J Med. 1975 Oct 9;293(15):735–739. doi: 10.1056/NEJM197510092931502. [DOI] [PubMed] [Google Scholar]
  12. Faden H., Bernstein J., Brodsky L., Stanievich J., Krystofik D., Shuff C., Hong J. J., Ogra P. L. Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis. 1989 Dec;160(6):999–1004. doi: 10.1093/infdis/160.6.999. [DOI] [PubMed] [Google Scholar]
  13. Giebink G. S. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis. Rev Infect Dis. 1981 Mar-Apr;3(2):342–353. doi: 10.1093/clinids/3.2.342. [DOI] [PubMed] [Google Scholar]
  14. Gnehm H. E., Pelton S. I., Gulati S., Rice P. A. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest. 1985 May;75(5):1645–1658. doi: 10.1172/JCI111872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Granoff D. M., Anderson E. L., Osterholm M. T., Holmes S. J., McHugh J. E., Belshe R. B., Medley F., Murphy T. V. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr. 1992 Aug;121(2):187–194. doi: 10.1016/s0022-3476(05)81186-2. [DOI] [PubMed] [Google Scholar]
  16. Green B. A., Doyle W. J., Cowell J. L. Chinchilla model of experimental otitis media for study of nontypable Haemophilus influenzae vaccine efficacy. Methods Enzymol. 1994;235:59–68. doi: 10.1016/0076-6879(94)35131-7. [DOI] [PubMed] [Google Scholar]
  17. Green B. A., Farley J. E., Quinn-Dey T., Deich R. A., Zlotnick G. W. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect Immun. 1991 Sep;59(9):3191–3198. doi: 10.1128/iai.59.9.3191-3198.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Green B. A., Metcalf B. J., Quinn-Dey T., Kirkley D. H., Quataert S. A., Deich R. A. A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae. Infect Immun. 1990 Oct;58(10):3272–3278. doi: 10.1128/iai.58.10.3272-3278.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Green B. A., Quinn-Dey T., Zlotnick G. W. Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun. 1987 Dec;55(12):2878–2883. doi: 10.1128/iai.55.12.2878-2883.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gulig P. A., McCracken G. H., Jr, Frisch C. F., Johnston K. H., Hansen E. J. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun. 1982 Jul;37(1):82–88. doi: 10.1128/iai.37.1.82-88.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kurono Y., Shimamura K., Mogi G. Inhibition of nasopharyngeal colonization of Hemophilus influenzae by oral immunization. Ann Otol Rhinol Laryngol Suppl. 1992 Oct;157:11–15. doi: 10.1177/0003489492101s1004. [DOI] [PubMed] [Google Scholar]
  22. Loeb M. R., Smith D. H. Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun. 1982 Sep;37(3):1032–1036. doi: 10.1128/iai.37.3.1032-1036.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Melhus A., Hermansson A., Akkoyunlu M., Forsgren A., Prellner K. Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies. Am J Otolaryngol. 1995 Nov-Dec;16(6):383–390. doi: 10.1016/0196-0709(95)90075-6. [DOI] [PubMed] [Google Scholar]
  24. Meuwissen J. H., Tauber I., Leeuwenberg A. D., Beckers P. J., Sieben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis. 1977 Jul;136(1):43–49. doi: 10.1093/infdis/136.1.43. [DOI] [PubMed] [Google Scholar]
  25. Moxon E. R., Smith A. L., Averill D. R., Smith D. H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis. 1974 Feb;129(2):154–162. doi: 10.1093/infdis/129.2.154. [DOI] [PubMed] [Google Scholar]
  26. Munson R. S., Jr, Granoff D. M. Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun. 1985 Sep;49(3):544–549. doi: 10.1128/iai.49.3.544-549.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Munson R. S., Jr, Shenep J. L., Barenkamp S. J., Granoff D. M. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J Clin Invest. 1983 Aug;72(2):677–684. doi: 10.1172/JCI111017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Musher D. M., Kubitschek K. R., Crennan J., Baughn R. E. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med. 1983 Oct;99(4):444–450. doi: 10.7326/0003-4819-99-4-444. [DOI] [PubMed] [Google Scholar]
  29. Shurin P. A., Rehmus J. M., Johnson C. E., Marchant C. D., Carlin S. A., Super D. M., Van Hare G. F., Jones P. K., Ambrosino D. M., Siber G. R. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr. 1993 Nov;123(5):801–810. doi: 10.1016/s0022-3476(05)80865-0. [DOI] [PubMed] [Google Scholar]
  30. Snapper C. M., Rosas F. R., Jin L., Wortham C., Kehry M. R., Mond J. J. Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol. 1995 Dec 15;155(12):5582–5589. [PubMed] [Google Scholar]
  31. Suzuki K., Bakaletz L. O. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun. 1994 May;62(5):1710–1718. doi: 10.1128/iai.62.5.1710-1718.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Teele D. W., Klein J. O., Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989 Jul;160(1):83–94. doi: 10.1093/infdis/160.1.83. [DOI] [PubMed] [Google Scholar]
  33. Yamanaka N., Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr. 1993 Feb;122(2):212–218. doi: 10.1016/s0022-3476(06)80115-0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES